{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:18:57Z","timestamp":1792441137664,"version":"4.5.0"},"reference-count":50,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>The aim of this review was to identify factors predicting actual or intended adherence to antivirals as treatment or prophylaxis for influenza. Literature from inception to March 2015 was systematically reviewed to find studies reporting predictors of adherence to antivirals and self\u2010reported reasons for non\u2010adherence to antivirals. Twenty\u2010six studies were included in the review; twenty identified through the literature search and six through other means. Of these studies, 18 assessed predictors of actual adherence to antivirals, whereas eight assessed predictors of intended adherence. The most commonly found predictor of, and self\u2010reported reason for, non\u2010adherence was the occurrence of side effects. Other predictors include perceptions surrounding self\u2010efficacy, response efficacy and perceived personal consequences as well as social influences of others' experiences of taking antivirals. Predictors identified in this review can be used to help inform communications to increase adherence to antivirals in both seasonal and pandemic influenza.<\/jats:p>","DOI":"10.1111\/irv.12406","type":"journal-article","created":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T08:19:56Z","timestamp":1468225196000},"page":"462-478","source":"Crossref","is-referenced-by-count":30,"title":["A systematic review of factors affecting intended and actual adherence with antiviral medication as treatment or prophylaxis in seasonal and pandemic flu"],"prefix":"10.1111","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1277-2564","authenticated-orcid":false,"given":"Louise E.","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Psychological Medicine King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"D'Antoni","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vageesh","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Pearce","sequence":"additional","affiliation":[{"name":"Department of War Studies King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Weinman","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. James","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,8]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70199-9"},{"key":"e_1_2_7_3_1","unstructured":"Tamiflu.Flu treatment for adults | tamiflu\u00ae(oseltamivir phosphate) 2014.http:\/\/www.tamiflu.com\/tamiflu-for-adults;jsessionid=uZNk-Cz2HqNTigzkzewSfZktw.gxe601a_node2. Accessed January 23 2014."},{"key":"e_1_2_7_4_1","volume-title":"Access to Clinical Trial Information and the Stockpiling of Tamiflu","author":"National Audit Office","year":"2013"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060221"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-8-135"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00091"},{"key":"e_1_2_7_8_1","unstructured":"World Health Organization.Adherence to long\u2010term therapies: evidence for action.http:\/\/www.who.int\/chronic_conditions\/adherencereport\/en\/2003. Accessed March 1 2016."},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-42"},{"key":"e_1_2_7_10_1","unstructured":"JacksonC EliassonL BarberN WeinmanJ.Applying COM\u2010B to medication adherence: A suggested framework for research and interventions. European Health Psychologist [Internet].2014.http:\/\/openhealthpsychology.net\/ehp\/issues\/2014\/v16iss1February2014\/16_1_EHP_Februay2014%20Jackson%20et%20al.pdf. Accessed February 2 2016."},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_2_7_12_1","volume-title":"Guidance on the Conduct of Narrative Synthesis in Systematic Reviews: Final Report","author":"Popay J","year":"2006"},{"key":"e_1_2_7_13_1","volume-title":"SIGN 50: A Guideline Developer's Handbook","author":"SIGN","year":"2014"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-442"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.06.037"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060204"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e318160c270"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00245.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1541-8"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-011-0865-y"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-2"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-296"},{"key":"e_1_2_7_24_1","doi-asserted-by":"crossref","first-page":"19287","DOI":"10.2807\/ese.14.30.19287-en","article-title":"Oseltamivir adherence and side effects among children in three London schools affected by influenza A(H1N1)v, May 2009 \u2013 an internet\u2010based cross\u2010sectional survey","volume":"14","author":"Kitching A","year":"2009","journal-title":"Euro Surveill"},{"key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"19312","DOI":"10.2807\/ese.14.33.19312-en","article-title":"Epidemiological and clinical characteristics of influenza A(H1N1)v infection in children: the first 45 cases in Cyprus, June \u2013 August 2009","volume":"14","author":"Koliou M","year":"2009","journal-title":"Euro Surveill"},{"key":"e_1_2_7_26_1","first-page":"176","article-title":"Antivirals management in Lancashire during the 2009 swine flu pandemic","volume":"285","author":"Lonsdale J","year":"2010","journal-title":"Pharm J"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12010"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/bsp.2009.0041"},{"key":"e_1_2_7_29_1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3855\/jidc.1318","article-title":"Pandemic influenza A(H1N1) 2009 virus outbreak among boarding school pupils in Madagascar: compliance and adverse effects of prophylactic oseltamivir treatment","volume":"5","author":"Rajatonirina S","year":"2011","journal-title":"J Infect Dev Ctries"},{"key":"e_1_2_7_30_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2807\/ese.15.19.19565-en","article-title":"Adverse drug effects following oseltamivir mass treatment and prophylaxis in a school outbreak of 2009 pandemic influenza A(H1N1) in June 2009, Sheffield, United Kingdom","volume":"15","author":"Strong M","year":"2010","journal-title":"Euro Surveill"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2011.11.014"},{"key":"e_1_2_7_32_1","doi-asserted-by":"crossref","first-page":"19285","DOI":"10.2807\/ese.14.30.19285-en","article-title":"Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England","volume":"14","author":"Wallensten A","year":"2009","journal-title":"Euro Surveill"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp10X514891"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatr.2009.299"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-257"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-9-30"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1258\/smj.2010.010017"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmr064"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq737"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2010.03.027"},{"key":"e_1_2_7_41_1","first-page":"7","article-title":"Applying COM\u2010B to medication adherence","volume":"16","author":"Jackson C","year":"2014","journal-title":"Eur Health Psychol"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12103"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000674"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2010.119875"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2651"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2011.01.016"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(99)80026-5"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000129496.05898.02"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/08870440512331317670"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2010.04.210"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00305.x"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Firv.12406","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.12406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T16:58:37Z","timestamp":1695747517000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.12406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1111\/irv.12406"],"URL":"https:\/\/doi.org\/10.1111\/irv.12406","archive":["Portico"],"relation":{},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,8]]}}}